Sign Up Today and Learn More About Stellaromics Stock
Invest in or calculate the value of your shares in Stellaromics or other pre-IPO companies through EquityZen's platform.
Stellaromics Stock
Stellaromics is a biotechnology company that specializes in 3D in situ multi-omic analysis technology.
About Stellaromics Stock
Founded
2022
Headquarters
Natick, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Stellaromics Press Mentions
Stay in the know about the latest news on Stellaromics
New MERFISH-Based Imaging Method Enables Whole-Embryo Spatial, Temporal Transcriptomics
genomeweb • Mar 17, 2026
AGBT: Spatial Biology Field 'Maturing' as Updates Well-Received, if Not Flashy
genomeweb • Mar 05, 2026
Omics in Orlando: A Video Report from AGBT, Day One
genengnews • Feb 27, 2026
Stellaromics Launches Pyxa™ at AGBT, the First Commercial Platform for 3D Spatial Multi-Omics in Intact Tissue
prnewswire • Feb 19, 2026
Stellaromics Appoints Industry Veterans Stacie Weninger and Steve McPhail to Board of Directors
prnewswire • Feb 10, 2026
Stellaromics Management
Leadership team at Stellaromics
Chief Technology Officer and Co-Founder
Ye Fu
Scientific Co-Founder and Scientific Advisor
Xiao Wang
Join now and verify your accreditation status to gain access to:
- Stellaromics Current Valuation
- Stellaromics Stock Price
- Stellaromics Management
- Available deals in Stellaromics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Stellaromics Cap Table and Funding History by Share Class and Liquidity Preferences
- Stellaromics Revenue and Financials
- Stellaromics Highlights
- Stellaromics Business Model
- Stellaromics Risk Factors
- Stellaromics Research Report from SACRA Research
Trading Stellaromics Stock
How to invest in Stellaromics stock?
Accredited investors can buy pre-IPO stock in companies like Stellaromics through EquityZen funds. These investments are made available by existing Stellaromics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Stellaromics stock?
Shareholders can sell their Stellaromics stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."